The global CGT CDMO market is projected to grow from US$ 4656.9 million in 2024 to US$ 16970 million by 2030, at a Compound Annual Growth Rate (CAGR) of 24.1% during the forecast period.

CGT CDMO Market

CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.

Market Analysis and Insights: Global CGT CDMO Market

Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

Report Covers:

This report presents an overview of global market for CGT CDMO market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of CGT CDMO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CGT CDMO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CGT CDMO revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CGT CDMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CGT CDMO revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of CGT CDMO Market Report

Report Metric	Details
Report Name	CGT CDMO Market
Accounted market size in 2024	US$ 4656.9 million
Forecasted market size in 2030	US$ 16970 million
CAGR	24.1
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Immune Cells Stem Cells Viral Vectors Plasmid DNA
Segment by Application	Pharmaceutical and Biotechnology Companies Research and Academic Institutions Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis, OBiO, GenScript, Pharmaron, Porton
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CGT CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CGT CDMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CGT CDMO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is CGT CDMO Market growing?

Ans: The CGT CDMO Market witnessing a CAGR of 24.1 during the forecast period 2024-2030.

What is the CGT CDMO Market size in 2030?

Ans: The CGT CDMO Market size in 2030 will be US$ 16970 million.

What is the market share of major companies in CGT CDMO Market?

Ans: The top three players hold a share over 60%.

What is the CGT CDMO Market share by region?

Ans: North America is the largest market, has a share about 50%.

What is the CGT CDMO Market share by type?

Ans: In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

Who are the main players in the CGT CDMO Market report?

Ans: The main players in the CGT CDMO Market are Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis, OBiO, GenScript, Pharmaron, Porton

What are the Application segmentation covered in the CGT CDMO Market report?

Ans: The Applications covered in the CGT CDMO Market report are Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Hospital, Others

What are the Type segmentation covered in the CGT CDMO Market report?

Ans: The Types covered in the CGT CDMO Market report are Immune Cells, Stem Cells, Viral Vectors, Plasmid DNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CGT CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Immune Cells

1.2.3 Stem Cells

1.2.4 Viral Vectors

1.2.5 Plasmid DNA

1.3 Market by Application

1.3.1 Global CGT CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research and Academic Institutions

1.3.4 Hospital

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CGT CDMO Market Perspective (2019-2030)

2.2 Global CGT CDMO Growth Trends by Region

2.2.1 CGT CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CGT CDMO Historic Market Size by Region (2019-2024)

2.2.3 CGT CDMO Forecasted Market Size by Region (2025-2030)

2.3 CGT CDMO Market Dynamics

2.3.1 CGT CDMO Industry Trends

2.3.2 CGT CDMO Market Drivers

2.3.3 CGT CDMO Market Challenges

2.3.4 CGT CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue CGT CDMO by Players

3.1.1 Global CGT CDMO Revenue by Players (2019-2024)

3.1.2 Global CGT CDMO Revenue Market Share by Players (2019-2024)

3.2 Global CGT CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of CGT CDMO, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global CGT CDMO Market Concentration Ratio

3.4.1 Global CGT CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CGT CDMO Revenue in 2023

3.5 Global Key Players of CGT CDMO Head office and Area Served

3.6 Global Key Players of CGT CDMO, Product and Application

3.7 Global Key Players of CGT CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CGT CDMO Breakdown Data by Type

4.1 Global CGT CDMO Historic Market Size by Type (2019-2024)

4.2 Global CGT CDMO Forecasted Market Size by Type (2025-2030)

5 CGT CDMO Breakdown Data by Application

5.1 Global CGT CDMO Historic Market Size by Application (2019-2024)

5.2 Global CGT CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CGT CDMO Market Size (2019-2030)

6.2 North America CGT CDMO Market Size by Type

6.2.1 North America CGT CDMO Market Size by Type (2019-2024)

6.2.2 North America CGT CDMO Market Size by Type (2025-2030)

6.2.3 North America CGT CDMO Market Share by Type (2019-2030)

6.3 North America CGT CDMO Market Size by Application

6.3.1 North America CGT CDMO Market Size by Application (2019-2024)

6.3.2 North America CGT CDMO Market Size by Application (2025-2030)

6.3.3 North America CGT CDMO Market Share by Application (2019-2030)

6.4 North America CGT CDMO Market Size by Country

6.4.1 North America CGT CDMO Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America CGT CDMO Market Size by Country (2019-2024)

6.4.3 North America CGT CDMO Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe CGT CDMO Market Size (2019-2030)

7.2 Europe CGT CDMO Market Size by Type

7.2.1 Europe CGT CDMO Market Size by Type (2019-2024)

7.2.2 Europe CGT CDMO Market Size by Type (2025-2030)

7.2.3 Europe CGT CDMO Market Share by Type (2019-2030)

7.3 Europe CGT CDMO Market Size by Application

7.3.1 Europe CGT CDMO Market Size by Application (2019-2024)

7.3.2 Europe CGT CDMO Market Size by Application (2025-2030)

7.3.3 Europe CGT CDMO Market Share by Application (2019-2030)

7.4 Europe CGT CDMO Market Size by Country

7.4.1 Europe CGT CDMO Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe CGT CDMO Market Size by Country (2019-2024)

7.4.3 Europe CGT CDMO Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China CGT CDMO Market Size (2019-2030)

8.2 China CGT CDMO Market Size by Type

8.2.1 China CGT CDMO Market Size by Type (2019-2024)

8.2.2 China CGT CDMO Market Size by Type (2025-2030)

8.2.3 China CGT CDMO Market Share by Type (2019-2030)

8.3 China CGT CDMO Market Size by Application

8.3.1 China CGT CDMO Market Size by Application (2019-2024)

8.3.2 China CGT CDMO Market Size by Application (2025-2030)

8.3.3 China CGT CDMO Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia CGT CDMO Market Size (2019-2030)

9.2 Asia CGT CDMO Market Size by Type

9.2.1 Asia CGT CDMO Market Size by Type (2019-2024)

9.2.2 Asia CGT CDMO Market Size by Type (2025-2030)

9.2.3 Asia CGT CDMO Market Share by Type (2019-2030)

9.3 Asia CGT CDMO Market Size by Application

9.3.1 Asia CGT CDMO Market Size by Application (2019-2024)

9.3.2 Asia CGT CDMO Market Size by Application (2025-2030)

9.3.3 Asia CGT CDMO Market Share by Application (2019-2030)

9.4 Asia CGT CDMO Market Size by Region

9.4.1 Asia CGT CDMO Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia CGT CDMO Market Size by Region (2019-2024)

9.4.3 Asia CGT CDMO Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America CGT CDMO Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Type

10.2.1 Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America CGT CDMO Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America CGT CDMO Market Size by Application

10.3.1 Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America CGT CDMO Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America CGT CDMO Market Size by Country

10.4.1 Middle East, Africa, and Latin America CGT CDMO Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Catalent

11.1.1 Catalent Company Details

11.1.2 Catalent Business Overview

11.1.3 Catalent CGT CDMO Introduction

11.1.4 Catalent Revenue in CGT CDMO Business (2019-2024)

11.1.5 Catalent Recent Developments

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza CGT CDMO Introduction

11.2.4 Lonza Revenue in CGT CDMO Business (2019-2024)

11.2.5 Lonza Recent Developments

11.3 Thermo Fisher

11.3.1 Thermo Fisher Company Details

11.3.2 Thermo Fisher Business Overview

11.3.3 Thermo Fisher CGT CDMO Introduction

11.3.4 Thermo Fisher Revenue in CGT CDMO Business (2019-2024)

11.3.5 Thermo Fisher Recent Developments

11.4 ACG Biologics

11.4.1 ACG Biologics Company Details

11.4.2 ACG Biologics Business Overview

11.4.3 ACG Biologics CGT CDMO Introduction

11.4.4 ACG Biologics Revenue in CGT CDMO Business (2019-2024)

11.4.5 ACG Biologics Recent Developments

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec CGT CDMO Introduction

11.5.4 WuXi AppTec Revenue in CGT CDMO Business (2019-2024)

11.5.5 WuXi AppTec Recent Developments

11.6 Charles River

11.6.1 Charles River Company Details

11.6.2 Charles River Business Overview

11.6.3 Charles River CGT CDMO Introduction

11.6.4 Charles River Revenue in CGT CDMO Business (2019-2024)

11.6.5 Charles River Recent Developments

11.7 Oxford Biomedica (OXB)

11.7.1 Oxford Biomedica (OXB) Company Details

11.7.2 Oxford Biomedica (OXB) Business Overview

11.7.3 Oxford Biomedica (OXB) CGT CDMO Introduction

11.7.4 Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2019-2024)

11.7.5 Oxford Biomedica (OXB) Recent Developments

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis CGT CDMO Introduction

11.8.4 Novartis Revenue in CGT CDMO Business (2019-2024)

11.8.5 Novartis Recent Developments

11.9 OBiO

11.9.1 OBiO Company Details

11.9.2 OBiO Business Overview

11.9.3 OBiO CGT CDMO Introduction

11.9.4 OBiO Revenue in CGT CDMO Business (2019-2024)

11.9.5 OBiO Recent Developments

11.10 GenScript

11.10.1 GenScript Company Details

11.10.2 GenScript Business Overview

11.10.3 GenScript CGT CDMO Introduction

11.10.4 GenScript Revenue in CGT CDMO Business (2019-2024)

11.10.5 GenScript Recent Developments

11.11 Pharmaron

11.11.1 Pharmaron Company Details

11.11.2 Pharmaron Business Overview

11.11.3 Pharmaron CGT CDMO Introduction

11.11.4 Pharmaron Revenue in CGT CDMO Business (2019-2024)

11.11.5 Pharmaron Recent Developments

11.12 Porton

11.12.1 Porton Company Details

11.12.2 Porton Business Overview

11.12.3 Porton CGT CDMO Introduction

11.12.4 Porton Revenue in CGT CDMO Business (2019-2024)

11.12.5 Porton Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Oxford Biomedica (OXB)

Novartis

ACG Biologics

Charles River

List of Tables

Table 1. Global CGT CDMO Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Immune Cells

Table 3. Key Players of Stem Cells

Table 4. Key Players of Viral Vectors

Table 5. Key Players of Plasmid DNA

Table 6. Global CGT CDMO Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global CGT CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global CGT CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global CGT CDMO Market Share by Region (2019-2024)

Table 10. Global CGT CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global CGT CDMO Market Share by Region (2025-2030)

Table 12. CGT CDMO Market Trends

Table 13. CGT CDMO Market Drivers

Table 14. CGT CDMO Market Challenges

Table 15. CGT CDMO Market Restraints

Table 16. Global CGT CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global CGT CDMO Revenue Share by Players (2019-2024)

Table 18. Global Top CGT CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2023)

Table 19. Global CGT CDMO Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by CGT CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of CGT CDMO, Headquarters and Area Served

Table 22. Global Key Players of CGT CDMO, Product and Application

Table 23. Global Key Players of CGT CDMO, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global CGT CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global CGT CDMO Revenue Market Share by Type (2019-2024)

Table 27. Global CGT CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global CGT CDMO Revenue Market Share by Type (2025-2030)

Table 29. Global CGT CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global CGT CDMO Revenue Share by Application (2019-2024)

Table 31. Global CGT CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global CGT CDMO Revenue Share by Application (2025-2030)

Table 33. North America CGT CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America CGT CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America CGT CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America CGT CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America CGT CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America CGT CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America CGT CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe CGT CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe CGT CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe CGT CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe CGT CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe CGT CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe CGT CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe CGT CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 47. China CGT CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 48. China CGT CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 49. China CGT CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 50. China CGT CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia CGT CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia CGT CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia CGT CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia CGT CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia CGT CDMO Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia CGT CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia CGT CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America CGT CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America CGT CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America CGT CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America CGT CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 65. Catalent Company Details

Table 66. Catalent Business Overview

Table 67. Catalent CGT CDMO Product

Table 68. Catalent Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 69. Catalent Recent Developments

Table 70. Lonza Company Details

Table 71. Lonza Business Overview

Table 72. Lonza CGT CDMO Product

Table 73. Lonza Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 74. Lonza Recent Developments

Table 75. Thermo Fisher Company Details

Table 76. Thermo Fisher Business Overview

Table 77. Thermo Fisher CGT CDMO Product

Table 78. Thermo Fisher Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 79. Thermo Fisher Recent Developments

Table 80. ACG Biologics Company Details

Table 81. ACG Biologics Business Overview

Table 82. ACG Biologics CGT CDMO Product

Table 83. ACG Biologics Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 84. ACG Biologics Recent Developments

Table 85. WuXi AppTec Company Details

Table 86. WuXi AppTec Business Overview

Table 87. WuXi AppTec CGT CDMO Product

Table 88. WuXi AppTec Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 89. WuXi AppTec Recent Developments

Table 90. Charles River Company Details

Table 91. Charles River Business Overview

Table 92. Charles River CGT CDMO Product

Table 93. Charles River Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 94. Charles River Recent Developments

Table 95. Oxford Biomedica (OXB) Company Details

Table 96. Oxford Biomedica (OXB) Business Overview

Table 97. Oxford Biomedica (OXB) CGT CDMO Product

Table 98. Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 99. Oxford Biomedica (OXB) Recent Developments

Table 100. Novartis Company Details

Table 101. Novartis Business Overview

Table 102. Novartis CGT CDMO Product

Table 103. Novartis Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 104. Novartis Recent Developments

Table 105. OBiO Company Details

Table 106. OBiO Business Overview

Table 107. OBiO CGT CDMO Product

Table 108. OBiO Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 109. OBiO Recent Developments

Table 110. GenScript Company Details

Table 111. GenScript Business Overview

Table 112. GenScript CGT CDMO Product

Table 113. GenScript Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 114. GenScript Recent Developments

Table 115. Pharmaron Company Details

Table 116. Pharmaron Business Overview

Table 117. Pharmaron CGT CDMO Product

Table 118. Pharmaron Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 119. Pharmaron Recent Developments

Table 120. Porton Company Details

Table 121. Porton Business Overview

Table 122. Porton CGT CDMO Product

Table 123. Porton Revenue in CGT CDMO Business (2019-2024) & (US$ Million)

Table 124. Porton Recent Developments

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CGT CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global CGT CDMO Market Share by Type: 2023 VS 2030

Figure 3. Immune Cells Features

Figure 4. Stem Cells Features

Figure 5. Viral Vectors Features

Figure 6. Plasmid DNA Features

Figure 7. Global CGT CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global CGT CDMO Market Share by Application: 2023 VS 2030

Figure 9. Pharmaceutical and Biotechnology Companies Case Studies

Figure 10. Research and Academic Institutions Case Studies

Figure 11. Hospital Case Studies

Figure 12. Others Case Studies

Figure 13. CGT CDMO Report Years Considered

Figure 14. Global CGT CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global CGT CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global CGT CDMO Market Share by Region: 2023 VS 2030

Figure 17. Global CGT CDMO Market Share by Players in 2023

Figure 18. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by CGT CDMO Revenue in 2023

Figure 20. North America CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America CGT CDMO Market Share by Type (2019-2030)

Figure 22. North America CGT CDMO Market Share by Application (2019-2030)

Figure 23. North America CGT CDMO Market Share by Country (2019-2030)

Figure 24. United States CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe CGT CDMO Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe CGT CDMO Market Share by Type (2019-2030)

Figure 28. Europe CGT CDMO Market Share by Application (2019-2030)

Figure 29. Europe CGT CDMO Market Share by Country (2019-2030)

Figure 30. Germany CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China CGT CDMO Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China CGT CDMO Market Share by Type (2019-2030)

Figure 38. China CGT CDMO Market Share by Application (2019-2030)

Figure 39. Asia CGT CDMO Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia CGT CDMO Market Share by Type (2019-2030)

Figure 41. Asia CGT CDMO Market Share by Application (2019-2030)

Figure 42. Asia CGT CDMO Market Share by Region (2019-2030)

Figure 43. Japan CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America CGT CDMO Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America CGT CDMO Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America CGT CDMO Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America CGT CDMO Market Share by Country (2019-2030)

Figure 53. Brazil CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries CGT CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Catalent Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 60. Lonza Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 61. Thermo Fisher Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 62. ACG Biologics Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 63. WuXi AppTec Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 64. Charles River Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 65. Oxford Biomedica (OXB) Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 66. Novartis Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 67. OBiO Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 68. GenScript Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 69. Pharmaron Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 70. Porton Revenue Growth Rate in CGT CDMO Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

CDMO Market

120 Pages

Type: Report

Code: QYRE-Auto-2X14886

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

IoT Smart Healthcare - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9W14014

Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Treating Localized Stretch Marks - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14S14078

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Cloud based Solutions for Drug Discovery Development and Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14N13847

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global CGT CDMO Market Insights, Forecast to 2030

Published Date: August 2024

Report Code: QYRE-Auto-34J6684

Global CGT CDMO Market Insights, Forecast to 2030

FEATURED COMPANIES

CGT CDMO Market Size

CGT CDMO Market

Scope of CGT CDMO Market Report

Chapter Outline

FAQ for this report

How fast is CGT CDMO Market growing?

What is the CGT CDMO Market size in 2030?

What is the market share of major companies in CGT CDMO Market?

What is the CGT CDMO Market share by region?

What is the CGT CDMO Market share by type?

Who are the main players in the CGT CDMO Market report?

What are the Application segmentation covered in the CGT CDMO Market report?

What are the Type segmentation covered in the CGT CDMO Market report?

FEATURED COMPANIES

RELATED REPORTS